(Alexandria, VA, Thursday, October 1, 2020) – The American Society of Clinical Oncology (ASCO) in collaboration with Harris Poll, will be releasing the fourth National Cancer Opinion Survey, which tracks the U.S. public’s views on cancer during the COVID-19 era, inequities in cancer care, and clinical trials.

As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect and need from the nation’s cancer care system. This year’s National Cancer Opinion Survey includes answers to the following questions:

• Do Americans believe various groups are receiving subpar cancer care?
• Do patients with cancer believe they received the best possible care?
• Have Americans had to delay or skip cancer treatments or routine care due to the pandemic?
• How has COVID-19 impacted Americans’ lives and health?
• What are Americans’ views on cancer clinical trials?

This fourth annual poll, being released on Thursday, October 1, was conducted online in the U.S. by The Harris Poll on behalf of ASCO between July 22-August 26, 2020, among 4,012 U.S. adults ages 18+ and more than 1,000 U.S. patients with cancer ages 18+.

ASCO’s National Cancer Opinion Survey was established in 2017 by the American Society of Clinical Oncology (ASCO), in collaboration with The Harris Poll, to track the U.S. public’s views on cancer research and care. As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect, and need from the nation’s cancer care system. The poll, supported by the Mission Endowment of Conquer Cancer, the ASCO Foundation, is designed to be conducted annually to measure shifts in the public’s perceptions of a range of cancer-related issues over time.